Show simple item record

Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse : the EMPOWER feasibility cluster RCT

dc.contributor.authorGumley, Andrew I.
dc.contributor.authorBradstreet, Simon
dc.contributor.authorAinsworth, John
dc.contributor.authorAllan, Stephanie
dc.contributor.authorAlvarez-Jimenez, Mario
dc.contributor.authorBirchwood, Maximillian
dc.contributor.authorBriggs, Andrew
dc.contributor.authorBucci, Sandra
dc.contributor.authorCotton, Sue
dc.contributor.authorEngel, Lidia
dc.contributor.authorFrench, Paul
dc.contributor.authorLederman, Reeva
dc.contributor.authorLewis, Shôn
dc.contributor.authorMachin, Matthew
dc.contributor.authorMaclennan, Graeme
dc.contributor.authorMcLeod, Hamish
dc.contributor.authorMcMeekin, Nicola
dc.contributor.authorMihalopoulos, Cathy
dc.contributor.authorMorton, Emma
dc.contributor.authorNorrie, John
dc.contributor.authorReilly, Frank
dc.contributor.authorSchwannauer, Matthias
dc.contributor.authorSingh, Swaran P.
dc.contributor.authorSundram, Suresh
dc.contributor.authorThompson, Andrew
dc.contributor.authorWilliams, Chris
dc.contributor.authorYung, Alison
dc.contributor.authorAucott, Lorna
dc.contributor.authorFarhall, John
dc.contributor.authorGleeson, John
dc.date.accessioned2024-02-07T08:16:29Z
dc.date.available2024-02-07T08:16:29Z
dc.date.issued2022-05
dc.identifier221983398
dc.identifier09738b5d-2d39-4d67-acf4-708592ef93ab
dc.identifier85131189606
dc.identifier35639493
dc.identifier.citationGumley , A I , Bradstreet , S , Ainsworth , J , Allan , S , Alvarez-Jimenez , M , Birchwood , M , Briggs , A , Bucci , S , Cotton , S , Engel , L , French , P , Lederman , R , Lewis , S , Machin , M , Maclennan , G , McLeod , H , McMeekin , N , Mihalopoulos , C , Morton , E , Norrie , J , Reilly , F , Schwannauer , M , Singh , S P , Sundram , S , Thompson , A , Williams , C , Yung , A , Aucott , L , Farhall , J & Gleeson , J 2022 , ' Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse : the EMPOWER feasibility cluster RCT ' , Health Technology Assessment , vol. 26 , no. 27 , pp. v-122 . https://doi.org/10.3310/HLZE0479en
dc.identifier.issn1366-5278
dc.identifier.otherORCID: /0000-0002-1039-5646/work/129409011
dc.identifier.otherORCID: /0000-0001-6277-7972/work/129409777
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/20055
dc.descriptionFunding Information: Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 26, No. 27. See the NIHR Journals Library website for further project information. Funding in Australia was provided by the National Health and Medical Research Council (APP1095879). Funding Information: The research reported in this issue of the journal was funded by the HTA programme as project number 13/154/04. The contractual start date was in April 2016. The draft report began editorial review in September 2019 and was accepted for publication in March 2020. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report. Funding Information: Declared competing interests of authors: Andrew I Gumley reports personal fees from the University of Manchester, the University of Exeter and the British Association for Behavioural & Cognitive Psychotherapies (BABCP) (Accrington, UK), and other interests with NHS Education for Scotland outside the submitted work. John Ainsworth reports other interests with Affigo CIC (Manchester, UK) outside the submitted work. Sandra Bucci is a director of Affigo CIC, a not-for-profit social enterprise company spun out of the University of Manchester in December 2015 to enable access to social enterprise funding and to promote ClinTouch, a symptom-monitoring app, to the NHS and public sector. Andrew Briggs reports personal fees from Bayer (Leverkusen, Germany), Merck Sharp & Dohme (Kenilworth, NJ, USA), Janssen Pharmaceutica (Beerse, Belgium), Novartis (Basel, Switzerland), SWORD Health (Porto, Portugal), Amgen Inc. (Thousand Oaks, CA, USA) and Daiichi Sankyo (Tokyo, Japan) outside the submitted work. John Farhall reports grants from the National Health and Medical Research Council (Australia) during the conduct of the study and other interests with Melbourne Health (NorthWestern Mental Health, Parkville, VIC, Australia) outside the submitted work. Shôn Lewis reports grants from the Medical Research Council, non-financial support from Affigo CIC and personal fees from XenZone plc (Manchester, UK) outside the submitted work. Cathy Mihalopoulos reports grants from National Health and Medical Research Council (Australia) during the conduct of the study. John Norrie reports grants from the University of Aberdeen and the University of Edinburgh during the conduct of the study and declares membership of the following NIHR boards: CPR Decision Making Committee (2016), HTA Commissioning Board (2010–16), HTA Commissioning Sub-Board (EOI) (2012–16), HTA Funding Boards Policy Group (2016), HTA General Board (2016–19), HTA Post-Board funding teleconference (2016–19), NIHR CTU Standing Advisory Committee (2017–present), NIHR HTA and EME Editorial Board (2014–19) and Pre-exposure Prophylaxis Impact Review Panel (2017–present). Paul French is a member of the HTA Mental Health Prioritisation Panel (2017–present). Chris Williams reports grants from NIHR during the conduct of the study (HTA 10/104/34 BEAT-IT: a randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with attention control; NIHR multicentre RCT of a group psychological intervention for postnatal depression in British mothers of South Asian Origin: RP-PG-0514-20012: Integrated therapist and online CBT for depression in primary care); other from Five Areas Ltd (Clydebank, UK) outside the submitted work; and that he has twice been president of the British Association for Behavioural & Cognitive Psychotherapies, the lead body for cognitive–bahavioural therapy in the UK. This body aims to advocate use of evidence-based delivery of cognitive–bahavioural therapy. Publisher Copyright: © Queen’s Printer and Controller of HMSO 2022.en
dc.format.extent208
dc.format.extent3315668
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectHealth Policyen
dc.subjectMedical Research Council (MRC)en
dc.subjectAPP1095879en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject13/154/04en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleDigital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse : the EMPOWER feasibility cluster RCTen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.3310/HLZE0479
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85131189606&partnerID=8YFLogxKen
dc.identifier.vol26en
dc.identifier.iss27en


Files in this item

Thumbnail
Name:
Guo_etal_Civil_Liberties_and_A ...
Size:
553.1Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record